Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_assertion type Assertion NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_head.
- NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_assertion description "[Osteopontin (OPN) plays important roles in tumor progression and metastasis through binding to OPN receptors such as alpha(v)beta(beta) integrin and CD44, and its overexpression in tumor is associated poor clinical outcome of NSCLC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_provenance.
- NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_assertion evidence source_evidence_literature NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_provenance.
- NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_assertion SIO_000772 17513004 NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_provenance.
- NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_assertion wasDerivedFrom befree-20140225 NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_provenance.
- NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_assertion wasGeneratedBy ECO_0000203 NP501602.RAZmf1SOP4Fi2hKkWpgJJkbdVT2UYCkzMmRbmwAUgyn1I130_provenance.